wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50953346-B910A0BE-0DB8-4D04-A052-1B7683979FEC
Q50953346-B910A0BE-0DB8-4D04-A052-1B7683979FEC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50953346-B910A0BE-0DB8-4D04-A052-1B7683979FEC
Comparison between the impact of morning and evening doses of rivaroxaban on the circadian endogenous coagulation rhythm in healthy subjects.
P2860
Q50953346-B910A0BE-0DB8-4D04-A052-1B7683979FEC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50953346-B910A0BE-0DB8-4D04-A052-1B7683979FEC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2f9ac5e506bf0a059aa0f5712b1128b9bc9e65cc
P2860
Anticoagulant therapy with the oral direct factor Xa inhibitors rivaroxaban, apixaban and edoxaban and the thrombin inhibitor dabigatran etexilate in patients with hepatic impairment.